BioCentury's streaming commentary on industry trends, plus interviews with leading KOLs.
Listen to BioCentury This Week on your favorite podcast service.
Podcast sponsorship opportunities are available. Contact Sarah Shoaff.
On BioCentury’s latest podcast, editors also discuss Aduhelm’s judgment day and ACTIV’s new look
BioCentury’s podcast team picks the wins for biotech this year
Plus the TIGIT landscape and leadership at NIH, FDA
Plus Emerging Company Spotlight featuring Anocca, AviadoBio and Chroma
BioCentury This Week podcast also features the latest strategies for optimizing the potency of TCR-based cancer therapies
BioCentury’s latest podcast discusses how Biogen’s next head of R&D should think about the biotech’s therapeutic focus
Biotech leaders from three continents, Debra Yu, Henk Joos and David Oxley, discuss RWE, medtech, precision medicine and China’s role in global deals
Jones Day’s Chen, McKinsey’s Zhang discuss the evolution of China’s biotech ecosystem
BioCentury’s latest podcast examines the priorities of FDA’s likely next commissioner
BeiGene’s Xiaobin Wu, Zai Lab’s Billy Cho on company priorities, finding talent and future bellwethers among China’s innovators
Build Back Better’s drug pricing provisions are likely to change investment decisions; it has a long road ahead
Emerging Company Spotlight: MoonLake, Walden
Emerging Company Spotlight: Elpiscience and Rectify
It’s been a year of setbacks spanning safety, efficacy and access, but the future looks bright